 |
 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Apriso.
No reviews have yet been submitted. Be the first to review this drug.
ChemoCentryx Announces Phase I Data With CCX507, Company's New Generation Orally Administered CCR9 Inhibitor CCX507 Reduces Colitis in Inflammatory...
Vitamin D supplements may help those with Crohn's disease overcome the fatigue and decreased muscle strength associated with the inflammatory bowel disease,...
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease First selective JAK1 inhibitor to enter Phase 2 studies in Crohn's disease...
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated May 17th, 2013), Cerner Multum™ (updated June 18th, 2013), Wolters Kluwer™ (updated June 17th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
